反应生成醋酸卡泊芬净 参考文献:Process For Preparation Of Caspofungin Acetate And Intermediates 标题:Process For Preparation Of Caspofungin Acetate And Intermediates 摘要:本发明公开了一种从肺炎链霉菌素b0制备卡泊芬净及其中间体的方法.
专利信息
专利号:US-2024336559-A1 优先权日:2021-10-06 标 题 :Anti-fungals compounds targeting the synthesis of fungal sphingolipids 发明人:OJIMA IWAO; HARANAHALLI KRUPANANDAN; DEL POETA MAURIZIO; GARG ASHNA 权利人:UNIV NEW YORK STATE RES FOUND 摘要:The present invention provides a compound having the structure: n n n n n n n n n n n n wherein n R 3 , R 4 , R 5 , R 6 , and R 7 are each independently, H, halogen, CN, —CF 3 , —OCF 3 , —NO 2 , alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycle, —OH, —OAc, —OR 13 , —COR 13 , —CH 2 OR 13 , —SH, —SR 13 , —SO 2 R 13 , —NH 2 , —NHR 13 , —NR 14 R 15 , —NHCOR 12 , or —CONR 14 R 15 ; n R 9 , R 10 , R 11 , and R 12 are each independently, H, CN, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, —OAc, —COR 13 , —SH, —SR 13 , —SO 2 R 13 , —NH 2 , —NHR 13 , —NR 14 R 15 , —NHCOR 12 , or —CONR 14 R 15 ;n wherein each occurrence of R 13 is independently alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R 14 is independently —H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R 15 is independently —H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, n n wherein when R 14 is methyl, R 15 is not methyl; n wherein at least one of R 9 , R 10 , R 11 , and R 12 is not H; n wherein at least one of R 3 , R 4 , R 5 , R 6 , and R 7 is not H.
专利号:US-12325678-B2 优先权日:2017-06-16 标 题 :Anti-fungals compounds targeting the synthesis of fungal sphingolipids 发明人:OJIMA IWAO; DEL POETA MAURIZIO; LAZZARINI CRISTINA; HARANAHALLI KRUPANANDAN; SUN YI 权利人:UNIV NEW YORK STATE RES FOUND 摘要:The present invention provides a compound having the structure: n nand use of the compound for inhibiting the growth of or killing.
专利号:US-11858880-B2 优先权日:2017-06-16 标题 :Anti-fungals compounds targeting the synthesis of fungal sphingolipids
专利号:US-2022298103-A1 优先权日:2014-12-08 标 题 :Anti-fungals targeting the synthesis of fungal shingolipids
专利号:US-2022394973-A1 优先权日:2017-06-16 标 题:Anti-fungals compounds targeting the synthesis of fungal sphingolipids
专利号:US-11414378-B2 优先权日:2017-06-16 标题 :Anti-fungals compounds targeting the synthesis of fungal sphingolipids
1: Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison T, Pappas PG; ReSTORE trial investigators. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25. 58(13):1206-14; quiz 1215-7. doi: 10.1093/ajhp/58.13.1206. 37(1):90-8. doi: 10.1345/aph.1C114. 58(19):1807-9. doi: 10.1093/ajhp/58.19.1807. 68(12):1981-1989. doi: 10.1093/cid/ciy827. 66(9):e0017722. doi: 10.1128/aac.00177-22. Epub 2022 Aug 15. 7: Thompson GR, Soriano A, Skoutelis A, Vazquez JA, Honore PM, Horcajada JP, Spapen H, Bassetti M, Ostrosky-Zeichner L, Das AF, Viani RM, Sandison T, Pappas PG. Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial. Clin Infect Dis. 2021 Dec 6;73(11):e3647-e3655. doi: 10.1093/cid/ciaa1380. Erratum in: Clin Infect Dis. 2021 Aug 2;73(3):561-562. 8: Sable CA, Nguyen BY, Chodakewitz JA, DiNubile MJ. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis. 2002 Mar;4(1):25-30. doi: 10.1034/j.1399-3062.2002.01004.x. 24(2):e172-e180. doi: 10.4317/medoral.22978.
合成参考文献
参考文献:10.1021/acs.est.5b03332 摘要:Singer HP, Wössner AE, McArdell CS, Fenner K. Rapid Screening for Exposure to "Non-Target" Pharmaceuticals from Wastewater Effluents by Combining HRMS-Based Suspect Screening and Exposure Modeling. Environ Sci Technol. 2016 Jul 05;50(13):6698–707. doi: 10.1021/acs.est.5b03332.